Clinical Trials Directory

Trials / Unknown

UnknownNCT04345640

The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.

The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver - The Pan Asia-Pacific Prospective Multi-centre Observational Study (APCOLIS STUDY)

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To address the existing deficiencies in the knowledge regarding liver involvement and spectrum of clinical presentation and the impact of COVID-19 infection in patients of liver disease was planned. The present study will be a hospital based and the cases of confirmed COVID-19 infection will be evaluated in relation to liver involvement irrespective of pre-existing liver disease. The primary objective was to address the clinical presentation, biochemical alteration and outcomes of COVID-19 infection in subjects with chronic hepatitis, cirrhosis in comparison to those having infection in the absence of pre-existing liver disease

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2020-04-10
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2020-04-14
Last updated
2020-09-03

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04345640. Inclusion in this directory is not an endorsement.